Assembly Biosciences (ASMB) Receivables (2017 - 2026)
Assembly Biosciences (ASMB) recorded quarterly Receivables of $451000.0 in Q1 2026, down 53.7% quarter-over-quarter from $974000.0 in Q4 2025.
Assembly Biosciences (ASMB) Receivables (2017 - 2026) Analysis & Trends
Assembly Biosciences' Receivables history runs 10 years deep, the most recent figure standing at $451000.0 for Q1 2026.
- In Q1 2026, Receivables changed N/A year-over-year to $451000.0; the TTM figure through Mar 2026 stood at $451000.0 (changed N/A YoY), while the FY2025 annual figure was $974000.0, changed N/A from the prior year.
- Receivables was $451000.0 for Q1 2026 at Assembly Biosciences, down from $974000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $1.2 million in Q3 2022 to a low of $43000.0 in Q4 2023.
- Historically, Receivables has averaged $610818.2 across 5 years, with a median of $524000.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Receivables jumped 180.95% in 2022, then plunged 95.44% in 2023.
- A 5-year view of Receivables shows it stood at $944000.0 in 2022, then slumped by 95.44% to $43000.0 in 2023, then changed by 0.0% to $43000.0 in 2024, then soared by 2165.12% to $974000.0 in 2025, then plunged by 53.7% to $451000.0 in 2026.
- The last three Receivables figures came in at $451000.0 (Q1 2026), $974000.0 (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | 451,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 451,000.00 |
| Dec 31, 2025 | 974,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Mar 31, 2024 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Jun 30, 2023 | 342,000.00 |
| Mar 31, 2023 | 717,000.00 |
| Dec 31, 2022 | 944,000.00 |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 523,000.00 |
| Mar 31, 2022 | 524,000.00 |
| Dec 31, 2021 | 336,000.00 |
| Sep 30, 2021 | 769,000.00 |
| Jun 30, 2021 | 297,000.00 |
| Mar 31, 2021 | 203,000.00 |
| Dec 31, 2020 | 1.23 Mn |
| Sep 30, 2020 | 3.59 Mn |
| Jun 30, 2020 | 3.30 Mn |
| Mar 31, 2020 | 3.06 Mn |
| Dec 31, 2019 | 3.37 Mn |